Neuronetics, Inc.
US ˙ NasdaqGM ˙ US64131A1051

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Wilfred E Jaeger. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Wilfred E Jaeger telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:STIM / Neuronetics, Inc. Director 138,563
US:CNCE / Concert Pharmaceuticals Inc Director 0
US:NVRO / Nevro Corp. Director 9,592
US:ACRX / Talphera, Inc. 10% Owner 0
US:THLD / Threshold Pharmaceuticals, Inc. Director 35,000
US:LPDX / Liposcience Inc 10% Owner 0
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Wilfred E Jaeger. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam STIM / Neuronetics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di STIM / Neuronetics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2018-07-02 STIM JAEGER WILFRED E 6,667 17.0000 6,667 17.0000 113,339 70 37.54 136,940 120.82

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

STIM / Neuronetics, Inc. Insider Trades
Penjualan Orang Dalam STIM / Neuronetics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di STIM / Neuronetics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

STIM / Neuronetics, Inc. Insider Trades
Pembelian Orang Dalam TLPH / Talphera, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di STIM / Neuronetics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2012-12-07 ACRX WAN MARK A 2,364,705 3.3100 118,235 66.2000 7,827,174 227 262.4 23,197,691 296.37
2012-12-07 ACRX WAN MARK A 52,213 3.3100 2,611 66.2000 172,825
2012-05-29 ACRX WAN MARK A 67,543 3.4000 3,377 68.0000 229,646
2012-05-29 ACRX WAN MARK A 3,631 3.4000 182 68.0000 12,345
2012-05-29 ACRX WAN MARK A 208,911 3.4000 10,446 68.0000 710,297
2012-05-29 ACRX WAN MARK A 4,613 3.4000 231 68.0000 15,684

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

TLPH / Talphera, Inc. Insider Trades
Penjualan Orang Dalam TLPH / Talphera, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di STIM / Neuronetics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

TLPH / Talphera, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Wilfred E Jaeger sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2023-05-30 2023-05-25 4 STIM Neuronetics, Inc.
Common Stock
A - Award 36,364 138,563 35.58
2023-03-06 2023-03-06 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
D - Sale to Issuer -16,400 0 -100.00
2023-03-06 2023-03-06 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
U - Other -5,125 0 -100.00
2022-06-13 2022-06-09 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
A - Award 16,400 21,525 320.00
2022-05-31 2022-05-26 4 STIM Neuronetics, Inc.
Common Stock
A - Award 38,910 102,187 61.49
2021-06-11 2021-06-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10,250 10,250
2021-06-11 2021-06-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
A - Award 5,125 5,125
2021-06-01 2021-05-27 4 STIM Neuronetics, Inc.
Common Stock
A - Award 7,137 63,289 12.71
2020-08-07 2020-08-05 4 STIM Neuronetics, Inc.
Common Stock
A - Award 18,513 56,152 49.19
2020-06-12 2020-06-11 4 CNCE CONCERT PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10,000 10,000
2020-05-28 2020-05-26 4 STIM Neuronetics, Inc.
Common Stock
A - Award 20,000 37,639 113.39
2020-05-26 2020-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 1,376 9,592 16.75
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 2,085 3,106 204.21
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 2,085 3,106 204.21
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 714 25,341 2.90
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 16,302 25,341 180.35
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 1,021 3,106 48.97
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 1,021 3,106 48.97
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 349 25,341 1.40
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 7,976 25,341 45.93
2020-01-06 2020-01-02 4 STIM Neuronetics, Inc.
Common Stock
A - Award 3,062 17,639 21.01 4.49 13,748 79,199
2019-10-03 2019-10-01 4 STIM Neuronetics, Inc.
Common Stock
A - Award 1,957 14,577 15.51 8.30 16,243 120,989
2019-07-02 2019-07-01 4 STIM Neuronetics, Inc.
Common Stock
A - Award 1,298 12,620 11.46 12.51 16,238 157,876
2019-06-17 2019-06-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (Right to Buy)
A - Award 10,000 10,000
2019-05-30 2019-05-28 4 STIM Neuronetics, Inc.
Stock Option (right to buy)
A - Award 7,347 7,347
2019-05-30 2019-05-28 4 STIM Neuronetics, Inc.
Common Stock
A - Award 3,723 11,322 48.99
2019-05-22 2019-05-20 4 NVRO NEVRO CORP
Common Stock
A - Award 2,913 8,216 54.93
2019-04-03 2019-04-01 4 STIM Neuronetics, Inc.
Common Stock
A - Award 932 7,599 13.98 14.75 13,747 112,085
2018-07-05 2018-07-02 4 STIM Neuronetics, Inc.
Stock Option (Right to Buy)
A - Award 8,767 8,767
2018-07-05 2018-07-02 4 STIM Neuronetics, Inc.
Common Stock
P - Purchase 6,667 6,667 17.00 113,339 113,339
2018-06-18 2018-06-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (Right to Buy)
A - Award 10,000 10,000
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -126,153 0 -100.00
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -5,713,569 0 -100.00
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -179,962 0 -100.00
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -3,347,357 0 -100.00
2018-05-23 2018-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 3,785 5,303 249.34
2018-03-07 2018-03-07 4 NVRO NEVRO CORP
Common Stock
S - Sale -1,461 11,042 -11.69 81.42 -118,958 899,064
2018-03-07 2018-03-07 4 NVRO NEVRO CORP
Common Stock
S - Sale -66,125 500,109 -11.68 81.42 -5,384,043 40,719,975
2018-03-07 2018-03-06 4 NVRO NEVRO CORP
Common Stock
S - Sale -1,098 12,503 -8.07 80.38 -88,258 1,005,000
2018-03-07 2018-03-06 4 NVRO NEVRO CORP
Common Stock
S - Sale -49,742 566,234 -8.08 80.38 -3,998,297 45,514,285
2018-03-07 2018-03-05 4 NVRO NEVRO CORP
Common Stock
S - Sale -910 13,601 -6.27 80.19 -72,969 1,090,610
2018-03-07 2018-03-05 4 NVRO NEVRO CORP
Common Stock
S - Sale -41,206 615,976 -6.27 80.19 -3,304,144 49,392,652
2018-03-01 2018-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -216 14,511 -1.47 80.48 -17,385 1,167,908
2018-03-01 2018-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -9,784 657,182 -1.47 80.48 -787,458 52,892,833
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -151 14,727 -1.01 81.36 -12,286 1,198,226
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -6,832 666,966 -1.01 81.36 -555,869 54,266,021
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -173 14,878 -1.15 83.09 -14,375 1,236,276
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -7,844 673,798 -1.15 83.09 -651,791 55,988,706
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -286 15,051 -1.86 83.20 -23,795 1,252,212
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -12,972 681,642 -1.87 83.20 -1,079,243 56,711,183
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -26 15,337 -0.17 84.17 -2,188 1,290,954
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -1,174 694,614 -0.17 84.17 -98,819 58,467,397
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -286 20,764 -1.36 90.31 -25,829 1,875,201
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -12,935 940,387 -1.36 90.31 -1,168,162 84,926,538
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -70 21,050 -0.33 89.72 -6,280 1,888,503
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -3,176 953,322 -0.33 89.72 -284,935 85,527,379
2017-08-24 2017-08-24 4 NVRO NEVRO CORP
Common Stock
S - Sale -158 21,120 -0.74 87.00 -13,746 1,837,440
2017-08-24 2017-08-24 4 NVRO NEVRO CORP
Common Stock
S - Sale -7,156 956,498 -0.74 87.00 -622,572 83,215,326
2017-08-24 2017-08-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -112 21,278 -0.52 87.01 -9,745 1,851,433
2017-08-24 2017-08-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -5,094 963,654 -0.53 87.01 -443,237 83,849,076
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -432 21,390 -1.98 86.48 -37,360 1,849,820
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -19,568 968,748 -1.98 86.48 -1,692,252 83,777,908
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -432 21,822 -1.94 85.17 -36,795 1,858,650
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -19,568 988,316 -1.94 85.17 -1,666,669 84,178,036
2017-08-21 2017-08-21 4 NVRO NEVRO CORP
Common Stock
S - Sale -540 22,254 -2.37 84.44 -45,600 1,879,228
2017-08-21 2017-08-21 4 NVRO NEVRO CORP
Common Stock
S - Sale -24,460 1,007,884 -2.37 84.44 -2,065,512 85,110,260
2017-08-21 2017-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -331 22,794 -1.43 84.02 -27,810 1,915,125
2017-08-21 2017-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -15,012 1,032,344 -1.43 84.02 -1,261,290 86,736,304
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -236 23,125 -1.01 84.04 -19,834 1,943,462
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -10,701 1,047,356 -1.01 84.04 -899,329 88,021,474
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -299 23,361 -1.26 82.75 -24,743 1,933,155
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -13,501 1,058,057 -1.26 82.75 -1,117,227 87,555,698
2017-08-16 2017-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -641 23,660 -2.64 82.54 -52,905 1,952,797
2017-08-16 2017-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -29,024 1,071,558 -2.64 82.54 -2,395,519 88,441,897
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -546 24,301 -2.20 82.40 -44,991 2,002,407
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -24,709 1,100,582 -2.20 82.40 -2,036,027 90,688,177
2017-06-19 2017-06-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (right to buy)
A - Award 10,000 10,000
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3,545 3,545
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1,518 1,518
2017-03-03 2017-03-03 4 NVRO NEVRO CORP
Common Stock
S - Sale -16 24,847 -0.06 95.00 -1,520 2,360,465
2017-03-03 2017-03-03 4 NVRO NEVRO CORP
Common Stock
S - Sale -703 1,125,291 -0.06 95.00 -66,785 106,902,645
2017-03-03 2017-03-02 4 NVRO NEVRO CORP
Common Stock
S - Sale -6 24,863 -0.02 95.00 -570 2,361,985
2017-03-03 2017-03-02 4 NVRO NEVRO CORP
Common Stock
S - Sale -294 1,125,994 -0.03 95.00 -27,930 106,969,430
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -928 24,869 -3.60 95.03 -88,191 2,363,383
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -42,033 1,126,288 -3.60 95.03 -3,994,535 107,034,865
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -79 25,797 -0.31 99.89 -7,891 2,576,847
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -137 25,876 -0.53 98.58 -13,505 2,550,727
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -3,567 1,168,321 -0.30 99.89 -356,305 116,702,884
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -6,217 1,171,888 -0.53 98.58 -612,841 115,518,860
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -370 26,013 -1.40 98.30 -36,372 2,557,161
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -1,034 26,383 -3.77 97.86 -101,192 2,581,964
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -16,753 1,178,105 -1.40 98.30 -1,646,874 115,811,491
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -46,843 1,194,858 -3.77 97.86 -4,584,276 116,934,420
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -50 27,417 -0.18 98.14 -4,907 2,690,608
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -1,459 27,467 -5.04 97.53 -142,300 2,678,922
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -216 28,926 -0.74 96.88 -20,926 2,802,391
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -2,250 1,241,701 -0.18 98.14 -220,807 121,856,190
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -66,066 1,243,951 -5.04 97.53 -6,443,576 121,325,527
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -9,799 1,310,017 -0.74 96.88 -949,341 126,916,281
2016-08-17 2016-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -661 29,142 -2.22 96.16 -63,559 2,802,161
2016-08-17 2016-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -29,953 1,319,816 -2.22 96.16 -2,880,143 126,907,435
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -73 29,803 -0.24 97.06 -7,086 2,892,801
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -457 29,876 -1.51 96.02 -43,880 2,868,601
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -3,327 1,349,769 -0.25 97.06 -322,932 131,014,113
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -20,689 1,353,096 -1.51 96.02 -1,986,494 129,920,083
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -121 30,333 -0.40 98.66 -11,938 2,992,608
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -2,039 30,454 -6.28 97.90 -199,617 2,981,437
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -5,487 1,373,785 -0.40 98.66 -541,339 135,535,567
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -92,353 1,379,272 -6.28 97.90 -9,041,331 135,030,315
2016-06-28 2016-06-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 35,000 35,000
2016-06-10 2016-06-09 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (right to buy)
A - Award 10,000 10,000
2016-05-20 2016-05-18 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3,240 3,240
2016-05-19 2016-05-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -29 32,493 -0.09 64.02 -1,857 2,080,182
2016-05-19 2016-05-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -1,314 1,471,625 -0.09 64.02 -84,121 94,212,550
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -78 32,522 -0.24 65.54 -5,112 2,131,365
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -174 32,600 -0.53 64.01 -11,137 2,086,628
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -3,522 1,472,939 -0.24 65.54 -230,818 96,530,678
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -7,866 1,476,461 -0.53 64.01 -503,479 94,503,839
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -91 32,774 -0.28 65.47 -5,957 2,145,609
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -2,069 32,865 -5.92 64.68 -133,813 2,125,544
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -4,140 1,484,327 -0.28 65.47 -271,033 97,174,139
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -93,700 1,488,467 -5.92 64.68 -6,060,048 96,266,603
2016-03-01 2015-11-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
J - Other -27,500 52,500 -34.38
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -113 0 -100.00 19.57 -2,211
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,066 0 -100.00 19.57 -99,119
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -265 0 -100.00 19.57 -5,185
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -4,916 0 -100.00 19.57 -96,184
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -589 113 -83.90 20.10 -11,841 2,272
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -26,697 5,066 -84.05 20.10 -536,719 101,847
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,392 265 -84.01 20.10 -27,985 5,328
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -25,894 4,916 -84.04 20.10 -520,576 98,832
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -42 702 -5.65 20.09 -844 14,102
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,919 31,763 -5.70 20.09 -38,549 638,058
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -100 1,657 -5.69 20.09 -2,009 33,286
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,861 30,810 -5.70 20.09 -37,384 618,914
2015-11-24 2015-11-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -540 34,934 -1.52 53.48 -28,880 1,868,312
2015-11-24 2015-11-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -24,460 1,582,167 -1.52 53.48 -1,308,150 84,616,190
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -696 35,474 -1.92 53.16 -36,999 1,885,773
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -2,040 36,170 -5.34 52.08 -106,237 1,883,618
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -31,496 1,606,627 -1.92 53.16 -1,674,305 85,407,167
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -92,400 1,638,123 -5.34 52.08 -4,811,896 85,308,204
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -1,045 38,210 -2.66 51.94 -54,276 1,984,589
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -47,323 1,730,523 -2.66 51.94 -2,457,909 89,881,634
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,296 744 -63.53 18.22 -23,613 13,556
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -58,704 33,682 -63.54 18.22 -1,069,587 613,686
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,062 1,757 -63.54 18.22 -55,790 32,013
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -56,938 32,671 -63.54 18.22 -1,037,410 595,266
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,805 2,040 -76.94 15.70 -106,838 32,028
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -308,195 92,386 -76.94 15.70 -4,838,662 1,450,460
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -16,071 4,819 -76.93 15.70 -252,315 75,658
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -298,929 89,609 -76.94 15.70 -4,693,185 1,406,861
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,404 8,845 -13.70 16.32 -22,913 144,350
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -63,596 400,581 -13.70 16.32 -1,037,887 6,537,482
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,316 20,890 -13.70 16.32 -54,117 340,925
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -61,684 388,538 -13.70 16.32 -1,006,683 6,340,940
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -996 10,249 -8.86 16.75 -16,683 171,671
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -45,112 464,177 -8.86 16.75 -755,626 7,774,965
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,352 24,206 -8.86 16.75 -39,396 405,450
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -43,755 450,222 -8.86 16.75 -732,896 7,541,218
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,056 11,245 -8.58 14.49 -15,301 162,937
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -47,837 509,289 -8.59 14.49 -693,144 7,379,445
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,494 26,558 -8.58 14.49 -36,137 384,817
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -46,398 493,977 -8.59 14.49 -672,293 7,157,579
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,056 11,245 -8.58 17.49 -18,469 196,672
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -47,837 509,289 -8.59 17.49 -836,655 8,907,312
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,494 26,558 -8.58 17.49 -43,619 464,491
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -46,398 493,977 -8.59 17.49 -811,487 8,639,510
2015-07-06 2015-05-26 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20,000 20,000
2015-06-15 2015-06-11 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (right to buy)
A - Award 10,000 10,000
2015-06-08 2015-06-08 4 NVRO NEVRO CORP
Common Stock
S - Sale -8,500 39,255 -17.80 47.94 -407,490 1,881,885
2015-06-08 2015-06-08 4 NVRO NEVRO CORP
Common Stock
S - Sale -384,968 1,777,846 -17.80 47.94 -18,455,366 85,229,937
2015-06-01 2015-05-28 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 4,182 4,182
2015-02-20 2015-02-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant (Right to Buy)
P - Purchase 25,000 25,000
2015-02-20 2015-02-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
P - Purchase 25,000 80,000 45.45 3.74 93,625 299,600
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,400 12,301 -30.51 12.29 -66,366 151,179
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -244,600 557,126 -30.51 12.29 -3,006,134 6,847,079
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -12,755 29,052 -30.51 12.29 -156,759 357,049
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -237,245 540,375 -30.51 12.29 -2,915,741 6,641,209
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series C Preferred Stock
C - Conversion -4,506 0 -100.00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series B Preferred Stock
C - Conversion -15,069 0 -100.00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series A Preferred Stock
C - Conversion -28,090 0 -100.00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series C Preferred Stock
C - Conversion -204,076 0 -100.00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series B Preferred Stock
C - Conversion -682,475 0 -100.00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series A Preferred Stock
C - Conversion -1,272,187 0 -100.00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 4,506 47,755 10.42
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 15,069 43,249 53.47
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 28,090 28,180 31,211.11
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 204,076 2,162,814 10.42
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 682,475 1,958,738 53.47
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 1,272,187 1,276,263 31,211.65
2014-11-07 2014-11-05 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 8,477 8,477
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8,242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4,256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8,242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4,256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8,242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4,256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8,242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4,256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8,242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4,256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8,242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4,256
2014-05-19 2014-05-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20,000 20,000
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -391,359 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -1,956,794 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -1,467,595 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -8,641 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -43,206 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -32,405 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 101,264 801,726 14.46 14.00 1,417,696 11,224,164
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 2,236 17,701 14.46 14.00 31,304 247,814
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 69,267 700,462 10.97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 346,335 631,195 121.58
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 259,751 284,860 1,034.49
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 1,529 15,465 10.97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 7,647 13,936 121.59
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 5,735 6,289 1,035.20
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -379,592 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -1,897,959 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -1,423,469 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -20,408 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -102,041 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -76,531 0 -100.00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 98,219 777,620 14.46 14.00 1,375,066 10,886,680
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 5,281 41,807 14.46 14.00 73,934 585,298
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 67,184 679,401 10.97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 335,922 612,217 121.58
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 251,941 276,295 1,034.50
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 3,612 36,526 10.97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 18,060 32,914 121.58
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 13,545 14,854 1,034.76
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26,972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50,017
2014-01-17 2014-01-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -4,907 0 -100.00 4.86 -23,832
2014-01-17 2014-01-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -91,449 0 -100.00 4.86 -444,140
2014-01-15 2014-01-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -10,204 4,907 -67.53 4.86 -49,561 23,833
2014-01-15 2014-01-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -189,796 91,449 -67.48 4.86 -921,839 444,168
2014-01-15 2014-01-14 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -5,000 15,111 -24.86 4.87 -24,330 73,530
2014-01-15 2014-01-14 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -93,000 281,245 -24.85 4.87 -452,538 1,368,538
2014-01-15 2014-01-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -6,477 20,111 -24.36 4.90 -31,705 98,443
2014-01-15 2014-01-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -120,479 374,245 -24.35 4.90 -589,745 1,831,929
2014-01-10 2014-01-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -14,286 26,588 -34.95 4.87 -69,597 129,529
2014-01-10 2014-01-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -265,714 494,724 -34.94 4.87 -1,294,479 2,410,147
2014-01-10 2014-01-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -10,204 40,874 -19.98 4.87 -49,668 198,954
2014-01-10 2014-01-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -189,796 760,438 -19.97 4.87 -923,832 3,701,432
2014-01-10 2014-01-08 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -12,444 51,078 -19.59 4.90 -60,957 250,206
2014-01-10 2014-01-08 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -231,456 950,234 -19.59 4.90 -1,133,787 4,654,721
2013-07-16 2013-07-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -4,552 63,522 -6.69 5.52 -25,118 350,514
2013-07-16 2013-07-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -84,648 1,181,690 -6.68 5.52 -467,088 6,520,565
2013-07-16 2013-07-12 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -11,877 68,074 -14.86 5.54 -65,787 377,062
2013-07-16 2013-07-12 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -220,923 1,266,338 -14.85 5.54 -1,223,692 7,014,246
2013-07-12 2013-07-11 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -5,918 79,951 -6.89 5.52 -32,672 441,385
2013-07-12 2013-07-11 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -110,082 1,487,261 -6.89 5.52 -607,730 8,210,722
2013-07-12 2013-07-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -3,163 85,869 -3.55 5.50 -17,400 472,374
2013-07-12 2013-07-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -58,837 1,597,343 -3.55 5.50 -323,668 8,787,144
2013-07-08 2013-07-05 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -4,897 89,032 -5.21 5.48 -26,836 487,895
2013-07-08 2013-07-05 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -91,070 1,656,180 -5.21 5.48 -499,064 9,075,866
2013-07-08 2013-07-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -6,311 93,929 -6.30 5.56 -35,089 522,245
2013-07-08 2013-07-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -117,389 1,747,250 -6.30 5.56 -652,683 9,714,710
2013-06-21 2013-06-19 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -102 100,240 -0.10 5.50 -561 551,671
2013-06-21 2013-06-19 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -1,898 1,864,639 -0.10 5.50 -10,446 10,262,041
2013-06-19 2013-06-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -3,649 100,342 -3.51 5.50 -20,075 552,021
2013-06-19 2013-06-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -67,862 1,866,537 -3.51 5.50 -373,336 10,268,567
2013-06-19 2013-06-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -2,715 103,991 -2.54 5.53 -15,006 574,758
2013-06-19 2013-06-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -50,507 1,934,399 -2.54 5.53 -279,152 10,691,423
2013-06-11 2013-06-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -2,735 106,706 -2.50 5.50 -15,043 586,915
2013-06-11 2013-06-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -50,865 1,984,906 -2.50 5.50 -279,773 10,917,578
2013-06-11 2013-06-07 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -5,102 109,441 -4.45 5.47 -27,893 598,325
2013-06-11 2013-06-07 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -94,898 2,035,771 -4.45 5.47 -518,817 11,129,764
2013-05-20 2013-05-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series F Convertible Preferred Stock
C - Conversion -25,261 0 -100.00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series F Convertible Preferred Stock
C - Conversion -534,339 0 -100.00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series E Convertible Preferred Stock
C - Conversion -41,509 0 -100.00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series E Convertible Preferred Stock
C - Conversion -878,030 0 -100.00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series D-1 Convertible Preferred Stock
C - Conversion -69,183 0 -100.00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series D-1 Convertible Preferred Stock
C - Conversion -1,463,385 0 -100.00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
P - Purchase 9,705 83,739 13.11 9.00 87,345 753,651
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
P - Purchase 205,295 1,771,347 13.11 9.00 1,847,655 15,942,123
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
C - Conversion 72,646 74,034 5,233.86
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
C - Conversion 1,536,688 1,566,052 5,233.24
2013-01-24 3 LPDX LIPOSCIENCE INC
Common Stock
29,364
2013-01-24 3 LPDX LIPOSCIENCE INC
Common Stock
1,388
2012-12-11 2012-12-07 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 52,213 139,621 59.73 3.31 172,825 462,146
2012-12-11 2012-12-07 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 2,364,705 6,323,534 59.73 3.31 7,827,174 20,930,898
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -12,500 20,000 -38.46
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -12,500 20,000 -38.46
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10,000 45,000 -18.18
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10,000 45,000 -18.18
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2,500 55,000 -4.35
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2,500 55,000 -4.35
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2,500 57,500 -4.17
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2,500 60,000 -4.00
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 12,500 55,000 29.41 1.64 20,500 90,200
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 12,500 42,500 41.67 1.62 20,250 68,850
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 30,000 50.00 1.95 19,500 58,500
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 20,000 14.29 1.30 3,250 26,000
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 20,000 14.29 1.30 3,250 26,000
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 15,000 20.00 1.30 3,250 19,500
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2,500 12,500 25.00 1.30 3,250 16,250
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 10,000 0.79 7,900 7,900
2012-08-27 2012-08-27 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -14,612 114,543 -11.31 7.98 -116,566 913,755
2012-08-27 2012-08-27 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -271,788 2,129,669 -11.32 7.98 -2,168,162 16,989,221
2012-08-27 2012-08-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -25,510 129,155 -16.49 8.02 -204,649 1,036,120
2012-08-27 2012-08-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -474,490 2,401,457 -16.50 8.02 -3,806,501 19,265,208
2012-08-23 2012-08-22 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -2,990 154,665 -1.90 7.52 -22,473 1,162,493
2012-08-23 2012-08-22 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -56,610 2,875,947 -1.93 7.52 -425,492 21,616,193
2012-08-23 2012-08-21 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -1,531 157,655 -0.96 7.50 -11,482 1,182,412
2012-08-23 2012-08-21 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -28,469 2,932,557 -0.96 7.50 -213,518 21,994,178
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -21,369 0 -100.00
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -20,007 21,369 -48.35
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -397,478 0 -100.00
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -372,149 397,478 -48.35
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 21,369 159,186 15.51 2.05 43,806 326,331
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 20,007 137,817 16.98 1.86 37,213 256,340
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 397,478 2,961,026 15.50 2.05 814,830 6,070,103
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 372,149 2,563,548 16.98 1.86 692,197 4,768,199
2012-07-17 2012-07-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -6,377 117,810 -5.13 8.01 -51,101 944,047
2012-07-17 2012-07-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -118,623 2,191,399 -5.14 8.01 -950,562 17,560,338
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 4,151 4,151 0.12 519 519
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 188,020 188,020 0.12 23,502 23,502
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 3,268 3,268 0.12 408 408
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 60,789 60,789 0.12 7,599 7,599
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 4,613 87,408 5.57 3.40 15,684 297,187
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 208,911 3,958,829 5.57 3.40 710,297 13,460,019
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 3,631 199,174 1.86 3.40 12,345 677,192
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 67,543 3,704,712 1.86 3.40 229,646 12,596,021
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 4,151 4,151 0.12 519 519
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 188,020 188,020 0.12 23,502 23,502
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 3,268 3,268 0.12 408 408
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 60,789 60,789 0.12 7,599 7,599
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 4,613 87,408 5.57 3.40 15,684 297,187
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 208,911 3,958,829 5.57 3.40 710,297 13,460,019
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 3,631 199,174 1.86 3.40 12,345 677,192
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 67,543 3,704,712 1.86 3.40 229,646 12,596,021
2012-05-21 2012-05-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2007-05-17 2007-05-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 15,000 15,000
2006-03-07 2006-03-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -1,000,000 2,440,202 -29.07 14.50 -14,500,000 35,382,929
2005-02-10 2005-02-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
P - Purchase 11,939 175,491 7.30 7.00 83,573 1,228,437
2005-02-10 2005-02-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
P - Purchase 222,059 3,264,711 7.30 7.00 1,554,413 22,852,977
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -154,607 0 -100.00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -2,875,696 0 -100.00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -114,750 0 -100.00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -2,135,250 0 -100.00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 93,877 163,552 134.74
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 1,746,126 3,042,652 134.68
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 69,675 69,675
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 1,296,526 1,296,526
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)